FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q94125669> ?p ?o ?g. }

• Q94125669 description "2019 nî lūn-bûn" @default.
• Q94125669 description "2019年の論文" @default.
• Q94125669 description "2019年学术文章" @default.
• Q94125669 description "2019年学术文章" @default.
• Q94125669 description "2019年学术文章" @default.
• Q94125669 description "2019年学术文章" @default.
• Q94125669 description "2019年学术文章" @default.
• Q94125669 description "2019年学术文章" @default.
• Q94125669 description "2019年學術文章" @default.
• Q94125669 description "2019年學術文章" @default.
• Q94125669 description "2019年學術文章" @default.
• Q94125669 description "2019年學術文章" @default.
• Q94125669 description "2019年學術文章" @default.
• Q94125669 description "2019년 논문" @default.
• Q94125669 description "article científic" @default.
• Q94125669 description "article scientific" @default.
• Q94125669 description "article scientifique" @default.
• Q94125669 description "articol științific" @default.
• Q94125669 description "articolo scientifico" @default.
• Q94125669 description "artigo científico" @default.
• Q94125669 description "artigo científico" @default.
• Q94125669 description "artigo científico" @default.
• Q94125669 description "artikel ilmiah" @default.
• Q94125669 description "artikull shkencor" @default.
• Q94125669 description "artikulong pang-agham" @default.
• Q94125669 description "artykuł naukowy" @default.
• Q94125669 description "artículo científico publicado en 2019" @default.
• Q94125669 description "artículu científicu" @default.
• Q94125669 description "bilimsel makale" @default.
• Q94125669 description "bài báo khoa học" @default.
• Q94125669 description "naučni članak" @default.
• Q94125669 description "scienca artikolo" @default.
• Q94125669 description "scientific article published on 23 October 2019" @default.
• Q94125669 description "scientific article published on 23 October 2019" @default.
• Q94125669 description "scientific article published on 23 October 2019" @default.
• Q94125669 description "teaduslik artikkel" @default.
• Q94125669 description "tieteellinen artikkeli" @default.
• Q94125669 description "tudományos cikk" @default.
• Q94125669 description "vedecký článok" @default.
• Q94125669 description "vetenskaplig artikel" @default.
• Q94125669 description "videnskabelig artikel udgivet 23. oktober 2019" @default.
• Q94125669 description "vitenskapelig artikkel" @default.
• Q94125669 description "vitskapeleg artikkel" @default.
• Q94125669 description "vědecký článek" @default.
• Q94125669 description "wetenschappelijk artikel" @default.
• Q94125669 description "wissenschaftlicher Artikel" @default.
• Q94125669 description "επιστημονικό άρθρο" @default.
• Q94125669 description "мақолаи илмӣ" @default.
• Q94125669 description "наукова стаття, опублікована в жовтні 2019" @default.
• Q94125669 description "научна статия" @default.
• Q94125669 description "научная статья" @default.
• Q94125669 description "научни чланак" @default.
• Q94125669 description "научни чланак" @default.
• Q94125669 description "מאמר מדעי" @default.
• Q94125669 description "مقالة علمية نشرت في 23 أكتوبر 2019" @default.
• Q94125669 description "২৩ অক্টোবর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q94125669 description "บทความทางวิทยาศาสตร์" @default.
• Q94125669 description "სამეცნიერო სტატია" @default.
• Q94125669 name "887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg R" @default.
• Q94125669 name "887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg R" @default.
• Q94125669 type Item @default.
• Q94125669 label "887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg R" @default.
• Q94125669 label "887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg R" @default.
• Q94125669 prefLabel "887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg R" @default.
• Q94125669 prefLabel "887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg R" @default.
• Q94125669 P1433 Q94125669-43DE46CD-028E-46CE-B0B5-EAD959E52EA5 @default.
• Q94125669 P1476 Q94125669-DAA8D87B-C421-4F3F-B6E2-7E7045CAE218 @default.
• Q94125669 P2093 Q94125669-669A20AC-B8CC-4F78-BB94-BD109AFC224D @default.
• Q94125669 P2093 Q94125669-77B734D3-948D-460C-B8B6-858B647D50D3 @default.
• Q94125669 P2093 Q94125669-781D1661-454F-4382-9E23-61590F9B5A95 @default.
• Q94125669 P2093 Q94125669-79E31D24-DD93-46C5-908A-D70E91AEF2B2 @default.
• Q94125669 P2093 Q94125669-E26238B2-2CB1-4B80-A142-708D8E6779EF @default.
• Q94125669 P2093 Q94125669-F3F06344-EC16-400C-9D16-E7CD108E9401 @default.
• Q94125669 P2093 Q94125669-F6161CEB-D243-43E6-A2D6-F6A8B8585490 @default.
• Q94125669 P2093 Q94125669-F790EBF2-6C60-4374-906E-C5EC3B450305 @default.
• Q94125669 P2093 Q94125669-FDA4DB3F-AD02-4B1D-827E-D048C4ACF1F1 @default.
• Q94125669 P275 Q94125669-86e7a3a5-bd02-4b71-b38a-67c4f036e807 @default.
• Q94125669 P304 Q94125669-7BCE0333-BDE3-4146-B726-F9A2AFFBF02D @default.
• Q94125669 P31 Q94125669-A400F72A-9559-4C47-9422-1135C6C1061E @default.
• Q94125669 P356 Q94125669-02689466-D982-4CF0-9FE5-5EC68A2212A8 @default.
• Q94125669 P433 Q94125669-291232FE-B569-4950-ADB2-F05733350122 @default.
• Q94125669 P478 Q94125669-8B986D35-D077-4BA1-8BF1-43CA138A2D7B @default.
• Q94125669 P577 Q94125669-8343FB18-CEF2-4BBF-B288-E016630F02D7 @default.
• Q94125669 P6216 Q94125669-53313aec-399b-4f22-a6bd-430e3ffb5ffa @default.
• Q94125669 P921 Q94125669-042B0E2F-F701-47EA-BA4D-60F5C6EDBF61 @default.
• Q94125669 P921 Q94125669-79F61B08-585A-4E72-90D9-D5FF19656929 @default.
• Q94125669 P932 Q94125669-65934BB3-1043-4E49-BE9C-D6C7F27A7D93 @default.
• Q94125669 P356 OFZ359.046 @default.
• Q94125669 P1433 Q27725953 @default.
• Q94125669 P1476 "887. High Rates of Virologic Suppression Achieved in HIV-1–Infected Adults Rapidly Starting Antiretroviral Therapy (ART) with the Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg Regardless of Baseline Disease Characteristics: Week 48 Subgroup Analyses From the Phase 3 DIAMOND Trial" @default.
• Q94125669 P2093 "Donghan Luo" @default.
• Q94125669 P2093 "Gordon Crofoot" @default.
• Q94125669 P2093 "Gregory D Huhn" @default.
• Q94125669 P2093 "Joseph Gathe" @default.
• Q94125669 P2093 "Keith Dunn" @default.
• Q94125669 P2093 "Moti Ramgopal" @default.
• Q94125669 P2093 "Patricia Cosler" @default.
• Q94125669 P2093 "Richard Bruce Simonson" @default.
• Q94125669 P2093 "Sareh Seyedkazemi" @default.
• Q94125669 P275 Q24082749 @default.

• next